Logo image of NUZE

NUZEE INC (NUZE) Stock Fundamental Analysis

NASDAQ:NUZE - Nasdaq - US67073S3076 - Common Stock - Currency: USD

0.7482  -0.04 (-5.04%)

After market: 0.76 +0.01 (+1.58%)

Fundamental Rating

1

NUZE gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 90 industry peers in the Food Products industry. NUZE may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, NUZE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NUZE had negative earnings in the past year.
In the past year NUZE has reported a negative cash flow from operations.
In the past 5 years NUZE always reported negative net income.
NUZE had a negative operating cash flow in each of the past 5 years.
NUZE Yearly Net Income VS EBIT VS OCF VS FCFNUZE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -5M -10M -15M

1.2 Ratios

Looking at the Return On Assets, with a value of -362.54%, NUZE is doing worse than 98.90% of the companies in the same industry.
Industry RankSector Rank
ROA -362.54%
ROE N/A
ROIC N/A
ROA(3y)-144.26%
ROA(5y)-156.18%
ROE(3y)-265.21%
ROE(5y)-249.59%
ROIC(3y)N/A
ROIC(5y)N/A
NUZE Yearly ROA, ROE, ROICNUZE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 1K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NUZE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NUZE Yearly Profit, Operating, Gross MarginsNUZE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -200 -400 -600 -800 -1K

More info and screens

0

2. Health

2.1 Basic Checks

NUZE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NUZE has more shares outstanding
Compared to 5 years ago, NUZE has more shares outstanding
The debt/assets ratio for NUZE is higher compared to a year ago.
NUZE Yearly Shares OutstandingNUZE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 200K 400K 600K
NUZE Yearly Total Debt VS Total AssetsNUZE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -49.46, we must say that NUZE is in the distress zone and has some risk of bankruptcy.
NUZE has a Altman-Z score of -49.46. This is amonst the worse of the industry: NUZE underperforms 97.80% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -49.46
ROIC/WACCN/A
WACC8.88%
NUZE Yearly LT Debt VS Equity VS FCFNUZE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 0.71 indicates that NUZE may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.71, NUZE is doing worse than 83.52% of the companies in the same industry.
NUZE has a Quick Ratio of 0.71. This is a bad value and indicates that NUZE is not financially healthy enough and could expect problems in meeting its short term obligations.
NUZE has a Quick ratio of 0.36. This is amonst the worse of the industry: NUZE underperforms 86.81% of its industry peers.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.36
NUZE Yearly Current Assets VS Current LiabilitesNUZE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M

More info and screens

6

3. Growth

3.1 Past

NUZE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.25%, which is quite impressive.
Looking at the last year, NUZE shows a quite strong growth in Revenue. The Revenue has grown by 19.20% in the last year.
NUZE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.23% yearly.
EPS 1Y (TTM)36.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.02%
Revenue 1Y (TTM)19.2%
Revenue growth 3Y33.74%
Revenue growth 5Y19.23%
Sales Q2Q%-43.61%

3.2 Future

Based on estimates for the next years, NUZE will show a very strong growth in Earnings Per Share. The EPS will grow by 38.62% on average per year.
NUZE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 114.62% yearly.
EPS Next Y71.17%
EPS Next 2Y38.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year100%
Revenue Next 2Y114.62%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NUZE Yearly Revenue VS EstimatesNUZE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
NUZE Yearly EPS VS EstimatesNUZE Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 -2 -4 -6 -8 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

NUZE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NUZE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NUZE Price Earnings VS Forward Price EarningsNUZE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NUZE Per share dataNUZE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

NUZE's earnings are expected to grow with 38.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.62%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NUZE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NUZEE INC

NASDAQ:NUZE (10/30/2024, 8:23:59 PM)

After market: 0.76 +0.01 (+1.58%)

0.7482

-0.04 (-5.04%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-19 2024-08-19/amc
Earnings (Next)01-15 2025-01-15/amc
Inst Owners1.47%
Inst Owner Change0.01%
Ins Owners59.6%
Ins Owner Change0%
Market Cap6.37M
Analysts82.86
Price Target8.16 (990.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-31.38%
Min EPS beat(2)-55.51%
Max EPS beat(2)-7.26%
EPS beat(4)0
Avg EPS beat(4)-45.47%
Min EPS beat(4)-73.65%
Max EPS beat(4)-7.26%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-64.04%
Min Revenue beat(2)-77.57%
Max Revenue beat(2)-50.51%
Revenue beat(4)1
Avg Revenue beat(4)-30.91%
Min Revenue beat(4)-77.57%
Max Revenue beat(4)9.62%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.69
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-7.37
EYN/A
EPS(NY)-0.84
Fwd EYN/A
FCF(TTM)-0.72
FCFYN/A
OCF(TTM)-0.69
OCFYN/A
SpS0.44
BVpS-0.02
TBVpS-0.03
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -362.54%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-144.26%
ROA(5y)-156.18%
ROE(3y)-265.21%
ROE(5y)-249.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 162.28%
Cap/Sales 7.85%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.71
Quick Ratio 0.36
Altman-Z -49.46
F-Score3
WACC8.88%
ROIC/WACCN/A
Cap/Depr(3y)30.88%
Cap/Depr(5y)115.94%
Cap/Sales(3y)4.27%
Cap/Sales(5y)27.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%65.02%
EPS Next Y71.17%
EPS Next 2Y38.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)19.2%
Revenue growth 3Y33.74%
Revenue growth 5Y19.23%
Sales Q2Q%-43.61%
Revenue Next Year100%
Revenue Next 2Y114.62%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-9.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y20.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y22.86%
OCF growth 3YN/A
OCF growth 5YN/A